Donald A. Denkhaus, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 60,000 shares at $2.48 ($149K) on 2018-12-14, disclosed to the SEC on 2018-12-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CPRX | BUY | 2018-12-28 | $48K | — | Filing → |
| CPRX | BUY | 2018-06-11 | $68K | — | Filing → |
| CPRX | BUY | 2018-05-31 | $75K | — | Filing → |